In Segment C, members will acquire ABBV-744 and oral navitoclax. In Phase D, members will get ABBV-744 and ruxolitinib. Members will obtain treatment until condition progression or even the individuals are not able to tolerate the study drugs. - Participant eaten grapefruit or grapefruit items within three times prior to https://angelosetep.blogolenta.com/28831915/5-easy-facts-about-is-abbv-744-effective-for-hematologic-cancers-described